Sionna Pharma (SION) Narx-foyda multiplikatori

Sionna Corp (SION) brendining ramzi va logotipi

Sionna Therapeutics Inc (SION) o'zining mustahkam ilmiy poydevori va aksiyalar opsionlari tizimi orqali yetakchi genetiklarni jalb qilmoqda. Emitentning P/E dinamikasi, hozirda ushbu ko'rsatkich -1.30 darajasida bo'lib, inson kapitali salohiyatini bozor baholashiga bog'laydi. Sionna Therapeutics Inc kistik fibrozga qarshi kurashish uchun noyob CFTR protein stabilizatorlarini ishlab chiqmoqda, bu esa radikal davolashga bo'lgan noelastik talab tufayli kompaniyaga mutlaq narx belgilash imkoniyatini beradi.

Sionna Therapeutics Inc - SION P/E multiplikatori (davr: 05.11.2025 - 17.11.2026)

Sionna Pharma (SION) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning jamlanma tahlili:Sionna Therapeutics - SION
Sionna Therapeutics, Inc. yetakchi tovari

Sionna Therapeutics Inc (SION) kompaniyasi o'zining tadqiqot va ishlanmalar (R&D) tarmog'i orqali kistik fibrozisni davolash nishasini monopolizatsiya qilishga e'tibor qaratgan bo'lib, kompaniyaning P/E ko'rsatkichi o'zgarishi kelgusidagi klinik natijalar bo'yicha bozor kutganlarini aks ettiradi. -1.30 ning joriy qiymati bozor kapitalizatsiyasining sof foydaga nisbati sifatida hisoblanadi, bu esa innovatsiya premiumini o'lchaydi va investor biznesning joriy daromadlarining har bir dollari uchun qancha to'lashini belgilaydi.

Muhim raqobatchilar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Beam Therapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti SRPT|twistbioscience.com (TWST) - Biznesning o‘zini qoplash muddati|P/E multiplikatori TXG|NTLA (Intellia) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Stoke STOK|BioLife (BLFS) - Kapitalizatsiyaning foydaga nisbati|wavelifesciences.com - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati MAZE|PRME: P/E multiplikatori|Taysha - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati uniQure NV|Narx-foyda multiplikatori MGTX (MeiraGTx PLC)|Narx-foyda koeffitsiyenti RGNX (regenxbio.com)|Solid Biosciences Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalizatsiyaning foydaga nisbati|BNTC - Narxning foydaga nisbati|Design Pharma - Bozor narxining sof foydaga nisbati|RCKT (Rocket Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|4D Molecular Therapeutics (FDMT) - P/E multiplikatori|Narxning foydaga nisbati Lexeo Therapeutics, Inc.|Kapitalizatsiyaning foydaga nisbati Korro Bio, Inc. KRRO|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati